Harpoon Therapeutics
Major Drugs - South San Francisco, CA, US
Harpoon Therapeutics Employees
Harpoon Therapeutics Senior Management
Harpoon Therapeutics Details
Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient's own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells. Using its proprietary Tri-specific T cell Activating Construct (TriTAC), platform, Harpoon is developing a pipeline of novel T cell engagers, or TriTACs, initially focused on the treatment of solid tumors and hematologic malignancies. Harpoon's first drug candidate, HPN424, is currently in Phase 1 clinical trial as a treatment for prostate cancer. For more information, please visit www.harpoontx.com.
Harpoon Therapeutics Technologies
Email Providers
Outlook
Load Balancers
Apache
Web Performance Monitoring
New Relic
Other
Mobile Friendly
Online Video Platforms
Vimeo
Analytics and Tracking
Google Analytics